Published in Lab Business Week, January 14th, 2007
The new facility, which will start production early in 2007, is designed to manufacture products for the treatment of cardiovascular disease, cancer and psychiatric disorders. The 7,000 sq. m plant will have three production lines with a capacity of 250 million tablets but this could be expanded to produce 400 million tablets a year.
Employment at the AstraZeneca Egypt Marketing Company has more than doubled during the past two years to a total strength of 350 employees and AstraZeneca has now set up a new regional office in Cairo responsible for Middle East & Northern...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.